000 01269 a2200373 4500
005 20250511200146.0
264 0 _c19910726
008 199107s 0 0 eng d
022 _a0098-1532
024 7 _a10.1002/mpo.2950190414
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aViana, M B
245 0 0 _aEtoposide in the treatment of six children with Langerhans cell histiocytosis (histiocytosis X)
_h[electronic resource]
260 _bMedical and pediatric oncology
_c1991
300 _a289-94 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aChild, Preschool
650 0 4 _aDrug Administration Schedule
650 0 4 _aEtoposide
_xadverse effects
650 0 4 _aFemale
650 0 4 _aHistiocytosis, Langerhans-Cell
_xcomplications
650 0 4 _aHumans
650 0 4 _aImmunologic Deficiency Syndromes
_xcomplications
650 0 4 _aInfant
650 0 4 _aLangerhans Cells
_xultrastructure
650 0 4 _aMale
650 0 4 _aRecurrence
650 0 4 _aRemission Induction
700 1 _aOliveira, B M
700 1 _aSilva, C M
700 1 _aRios Leite, V H
773 0 _tMedical and pediatric oncology
_gvol. 19
_gno. 4
_gp. 289-94
856 4 0 _uhttps://doi.org/10.1002/mpo.2950190414
_zAvailable from publisher's website
999 _c1675948
_d1675948